Stock Analysis on Net
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Common-Size Income Statement

Abiomed Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Revenue 100.00 100.00 100.00 100.00 100.00 100.00
Cost of revenue -18.24 -19.10 -17.99 -16.84 -16.60 -15.86
Gross profit 81.76% 80.90% 82.01% 83.16% 83.40% 84.14%
Research and development -15.84 -14.38 -11.74 -12.15 -12.68 -14.91
Selling, general and administrative -41.05 -39.43 -40.62 -41.79 -44.25 -48.99
Acquired in-process research and development -11.24 0.00 0.00 0.00 0.00 0.00
Income from operations 13.64% 27.09% 29.64% 29.22% 26.47% 20.24%
Interest and other income, net 4.83 6.92 0.90 5.01 0.61 0.35
Interest expense 0.00 0.00 0.00 0.00 -0.05 -0.08
Income before income taxes 18.47% 34.01% 30.54% 34.23% 27.02% 20.51%
Income tax provision -5.24 -7.40 -6.40 -0.56 -8.13 -8.81
Net income 13.23% 26.61% 24.14% 33.66% 18.89% 11.70%

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

Income statement item Description The company
Income from operations The net result for the period of deducting operating expenses from operating revenues. Abiomed Inc. income from operations as a percentage of revenue decreased from 2020 to 2021 and from 2021 to 2022.
Income before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Abiomed Inc. income before income taxes as a percentage of revenue increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.
Net income The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Abiomed Inc. net income as a percentage of revenue increased from 2020 to 2021 but then decreased significantly from 2021 to 2022.